drugset / Trial / NCT00236834
A Study of the Safety and Effectiveness of Levofloxacin Compared With Imipenem/Cilastatin in Patients With Pneumonia Acquired During Hospitalization
Phase 3
Completed
438 enrolled
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
PriCara, Unit of Ortho-McNeil, Inc. · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to compare the safety and effectiveness of levofloxacin with imipenem/cilastatin in the treatment of hospital-acquired pneumonia
Timeline
- Start
- 1997-12
- Primary completion
- —
- Completion
- 2001-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Levofloxacin | Small molecule | 750 mg | Intravenous |
| Subject | imipenem/cilastatin | Unknown | 500 mg | Intravenous |
| Subject | imipenem/cilastatin | Unknown | 1 g | Intravenous |